Green tea compound has lifesaving potential: Study

Green tea compound has lifesaving potential: Study

8:14 AM, 13th February 2017
A compound in green tea could have lifesaving potential for patients with multiple myeloma and amyloidosis. (File photo)
A compound in green tea could have lifesaving potential for patients with multiple myeloma and amyloidosis. (File photo)

WASHINGTON, US: A team of engineers at Washington University in St Louis (WUSTL) and with their German partners have found that a compound in green tea could have a lifesaving potential for patients with multiple myeloma and amyloidosis. And who face often-fatal medical complications associated with bone marrow disorders.

Jan Bieschke, assistant professor of biomedical engineering at the School of Engineering & Applied Science, studied how proteins fold and shape themselves, and how these processes can contribute to a variety of diseases. He said the compound epigallocatechine-3-gallate (EGCG), a polyphenol found in green tea leaves, may be of particular benefit to patients struggling with multiple myeloma and amyloidosis.

These patients are susceptible to a frequently fatal condition called light chain amyloidosis, in which parts of the body’s own antibodies become misshapen and can accumulate in various organs, including the heart and kidneys.

The research is published in the journal of Biological Chemistry.

“The idea here is twofold: We wanted to better understand how light chain amyloidosis works, and how the green tea compound affects this specific protein,” Bieschke said.

Bieschke’s team first isolated individual light chains from nine patients with bone marrow disorders that caused multiple myeloma or amyloidosis, then ran lab experiments to determine how the green tea compound affected the light chain protein.

Bieschke previously examined EGCG’s effect in both Parkinson’s and Alzheimer’s disease and found it prevented dangerous buildups of protein present in both diseases. His team had a similar conclusion in this study: In the lab using samples from bone marrow patients, the EGCG transformed light chain amyloid, preventing the misshapen form from replicating and accumulating dangerously.

“In the presence of green tea, the chains have a different internal structure,” Bieschke said. “The ECGC pulled the light chain into a different type of aggregate that wasn’t toxic and didn’t form fibril structures,” as happens to organs affected by amyloidosis.

While Bieschke is gaining a greater understanding of the intracellular processes involved, his partners at the University of Heidelberg are working in tandem with him, running clinical trials.

“My group is looking at the mechanism of the protein in a test tube; we are studying how it works on a foundational level. At the same time, clinical trials at the Amyloidosis Center in Heidelberg, with Alzheimer’s in Berlin and with Parkinson’s in China examine the process in people. We all want this compound to work in a patient,” he concluded.

© WUSTL News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Three projects of PPG named among top structures of 2016

PITTSBURGH, US: PPG Industries Inc said that three projects finished with PPG protective and marine coatings products were recognised by the Society o ...

Read more
BASF, European Space Agency to develop digital services for farmers

LIMBURGERHOF, GERMANY: BASF SE and the European Space Agency (ESA) signed a collaboration agreement to evaluate how satellite-derived data and images ...

Read more
PPG receives DOE funding to develop silica fillers for non-tread tire components

PITTSBURGH, US: PPG Industries Inc said that the US Department of Energy (DOE) will provide funding to support a $1.14 million project to develop new ...

Read more
Archroma to build new tetrasulfonated OBAs production facility in Spain

REINACH, SWITZERLAND: Archroma said that it will invest in a new production facility for tetrasulfonated optical brightening agents (OBAs) at its exis ...

Read more
PPG introduces new colour management software, hardware tools

STRONGSVILLE, US: PPG Industries’ automotive refinish business said that it has developed several key advances in its popular array of colour so ...

Read more
Systec to unveil new autoclaves, media preparators devices

LINDEN, GERMANY: Systec GmbH, the leading manufacturer of autoclaves, including laboratory autoclaves, media preparators, and dispensing devices for l ...

Read more